Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy
NCT ID: NCT01726205
Last Updated: 2012-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
45 participants
INTERVENTIONAL
2008-10-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregabalin
perioperative pregabalin starting the evening before surgery, and for five days postoperatively
Pregabalin and normal saline infusion, PRG
pregabalin and continuous wound infusion
Pregabalin as previous group and continuous infusion of ropivacaine 0.2% via a wound catheter
Pregabalin and ropivacaine 02% infusion
placebo
Placebo drug and normal saline infusion
Placebo drug, normal saline infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pregabalin and normal saline infusion, PRG
Pregabalin and ropivacaine 02% infusion
Placebo drug, normal saline infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI \> 30
* preoperative Hb \< 10 mg/dL
* preexistent chronic pain
* neurologic disease
* chronic assumption of alcohol
* treatment with analgesics, anxiolytics, sedatives, antidepressants, or calcium channel inhibitors
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Attikon Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sidiropoulou Tatiana
Lecturer in Anesthesiology, University of Athens
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tatiana Sidiropoulou
Role: PRINCIPAL_INVESTIGATOR
Attikon Hospital
Eyaggelos Giavasopoulos
Role: PRINCIPAL_INVESTIGATOR
Attikon Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Attikon Hospital
Athens, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRGCWI1
Identifier Type: -
Identifier Source: org_study_id